Ampio Pharma (AMPE) Reports Delay in STEP Study Analysis; Cites Exposure to Lower Temps
Tweet Send to a Friend
Ampio Pharma (NYSE: AMPE) announced a delay in the data analysis of the STEP Study due to the discovery by ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
